One-fifth of hospitalizations in advanced GI cancer avoidable

One-fifth of hospitalizations in advanced GI cancer avoidable

(HealthDay)—For patients with advanced gastrointestinal (GI) cancer, about 20 percent of hospitalizations are potentially avoidable, according to a study published online Jan. 13 in the Journal of Clinical Oncology.

Gabriel A. Brooks, M.D., and colleagues from the Dana-Farber Cancer Institute in Boston, and colleagues conducted a retrospective study to identify and characterize potentially avoidable hospitalization in with GI malignancies. A total of 201 hospitalizations were included for 154 unique patients (median age, 62 years) admitted to an inpatient medical oncology or palliative care service between December 2011 and July 2012.

The researchers found that the most common diagnosis was colorectal cancer (32 percent) and that most hospitalized patients (81 percent) had metastatic disease. More than half of hospitalizations (53 percent) were due to cancer symptoms and more than one-quarter (28 percent) were due to cancer treatment complications. Nineteen percent of hospitalizations were considered potentially avoidable by medical oncologists. Potentially avoidable hospitalizations were more likely among patients aged ≥70 years (odds ratio [OR], 2.63); those who had received advice from an oncologist to consider hospice (OR, 6.09); and those who had received three or more lines of chemotherapy (OR, 2.68). Higher 90-day mortality was observed after avoidable hospitalizations versus non-avoidable hospitalizations (OR, 6.4).

"Potentially avoidable hospitalizations are common in patients with advanced GI ," the authors write. "The majority of potentially avoidable hospitalizations occurred in patients with advanced treatment-refractory cancers near the end of life."

More information: Abstract
Full Text

Related Stories

Recommended for you

HLA expression tied to penile cancer outcomes

date 12 hours ago

(HealthDay)—Human leukocyte antigen (HLA) expression appears to be tied to clinical outcomes in penile cancer, according to a study published in the April issue of The Journal of Urology.

Study points to potential new lung cancer therapy

date 12 hours ago

New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, has shown therapeutic promise for several cancers, including the most common form of lung cancer.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.